2024 NPA Annual Conference

LATE REGISTRATION (March 2, 2024 - March 16, 2024)

Graduate student or postdoc member: $599

Non-postdoc member/Organizational Member primary contact: $799

Non-member: $999

The top priority of the NPA for all in-person meetings is the safety and welfare of our attendees and staff.

The NPA will follow the strictest guidelines in place at the time of the Conference by the Hyatt Regency Seattle the city or county department of public health in which the Conference is located, and/or the state of Washington.

By registering for the Conference, you hereby voluntarily assume all risks and accept sole responsibility for any injury related to exposure to COVID-19, and release the NPA, its officers and directors, contractors, subcontractors and volunteers from liability for any injury or harm that may result from attending the Conference. The NPA’s goal is to ensure a safe meeting environment. As such, you also agree to abide by the stricter of any prevention or safety measures that the NPA, the Hyatt Regency Seattle, the county or city health department where the Conference is located, or the state of Washington may have in place during the Conference. You also agree not to attend the Conference if you become ill, are aware that you’ve been directly exposed to the COVID-19 virus within two weeks prior to the Conference, or exhibit any symptoms of the COVID-19 virus prior to or during the Conference. In such a case, the NPA will make best efforts to refund your registration fees less any expenses already incurred or obligated by the NPA.

Senior Vice President, Research and Early Development Immuno-Oncology and Cell Therapy
Bristol Myers Squibb

Teresa (Teri) Foy is an immunologist with more than 25 years of biotechnology and pharmaceutical industry experience developing novel therapeutics in the areas of oncology and inflammation. At Bristol Myers Squibb (BMS), she leads the Cancer Immunology and Cell Therapy Thematic Research Center. With a mission to drive leadership in the development of immune-based therapies in hematological and solid cancers, she and her team focus on the development and translation of BMS’ early cancer immunology and cell therapy pipeline from discovery through human proof of concept. As part of her research, she also oversees close collaborations with other key research areas across the company, as well as external scientific and business development partnerships.

Prior to her role at BMS, Foy worked at Celgene for more than five years. She was instrumental in building the immune-oncology and cell therapy strategy and pipeline. Earlier in her career, she held Seattle-based scientific leadership positions at Corixa Corp. and GlaxoSmithKline. She also served as the chief scientific officer at VLST, a private company focused on developing therapeutics for autoimmune and inflammatory diseases.

Foy earned her doctorate in immunology from the University of Iowa, a master’s degree in microbiology, and completed her postdoctoral fellowship in immunology at Dartmouth Medical School. She has an extensive publication record and holds nearly a dozen patents for novel immune compositions. She also serves as a member of the Board of Directors of Nanostring Technologies and Life Science Washington.

Professor and Associate Director, Basic Sciences Division
Fred Hutchinson Cancer Center

Bio taken from this site.

"Dr. Harmit Malik studies genetic conflict, the competition between genes and proteins with opposing functions that drives evolutionary change. His research could have implications for a range of diseases, from HIV to cancer. As part of this work, his team developed an approach for identifying genes that divide one species from another, which could help solve the riddle of how new species evolve. Dr. Malik also studies the evolutionary processes that drive our body’s interactions with viruses, including contemporary scourges like HIV as well as ancient viruses whose fossils litter our genome. With Hutch colleagues, he has characterized the rapidly evolving interface between proteins on human cells and viruses that make us sick. This work has highlighted surprising deviations from 'textbook' models of these interactions, and it is revealing gene variants that could influence our susceptibility to infection."

Agenda subject to change

The NPA’s Annual Conference is the largest international conference and networking event dedicated to the postdoctoral community. As a sponsor of our Annual Conference, we provide you with an invaluable opportunity to interact with postdocs, postdoc office administrators, government agencies, and industry representatives. Your organization will have the opportunity to discuss policy, enhance career development, and effect meaningful change in local and/or national postdoctoral communities. Sponsoring our event is a great opportunity to reach and interact with this community to build long-lasting, collaborative relationships.

Organizations who wish to engage with postdoctoral scholars, postdoctoral program administrators, graduate students considering postdoctoral research positions, faculty, and anyone with a vested interest in postdoctoral scholars.

View the 2024 Annual Conference sponsorship prospectus.

IMPORTANT INFORMATION: 1. There are a limited number of sponsorship packages, and these will be sold on a first-come, first-served basis. 2. Sponsors understand that all attendees must officially register for the conference. During the transaction, please provide the contact information for the individual who should receive all future sponsorship correspondence. 3. Please read through the terms on each respective product page to familiarize yourself of deadlines and sponsorship specifics.

The NPA is a 501(c)3 nonprofit organization, and your sponsorship may be considered a tax-deductible contribution, according to the limits of the law. For example, the portion of your sponsorship attributed to an ad in the program book may not be tax-deductible, depending on ad content.

Lodging for the conference will be at the Hyatt Regency Seattle, 808 Howell St, Seattle, WA 98101. A special rate of $189 per night (plus tax) has been negotiated for NPA conference attendees. The rate is valid through February 20, 2024. Book your room at this link!